Written by Heather Yoshimura, MSN, AGNP-BC Evidence-based · Peer-reviewed sources cited Last updated: March 7, 2026

I spent years being told I had IBS. Elimination diets, FODMAP protocols, a GI specialist who was genuinely kind but looking at the wrong diagnosis. The bloating, the urgency, the unpredictable cramping — it was all endometriosis. My gut wasn't the problem. It was responding to endometriosis that nobody had found yet.

This is remarkably common. Many endometriosis patients spend years being diagnosed with IBS before someone asks the right question. Not because gastroenterologists are incompetent — they're not — but because endometriosis can present with digestive symptoms that overlap significantly with IBS. Understanding the mechanisms connecting these conditions can help you get the right diagnosis and treatment.

How Common Are GI Symptoms in Endometriosis?

Up to 90% of people with endometriosis experience GI symptoms including constipation, bloating, and nausea. Women with endometriosis are approximately 3 times more likely to meet criteria for IBS than women without endometriosis — a finding confirmed across multiple meta-analyses.

These digestive symptoms often happen even when endometriosis doesn't directly involve the bowel. The inflammation from endometriosis lesions anywhere in the pelvis can affect gut function through inflammatory signaling, immune system changes, and nervous system sensitization.

What Is the Estrobolome and How Does It Relate to Endometriosis?

The estrobolome is the collection of gut bacteria that produce enzymes — particularly beta-glucuronidase and sulfatases — capable of metabolizing estrogen. These enzymes deconjugate estrogen that the liver has already processed for excretion, allowing it to be reabsorbed into circulation rather than eliminated. When the bacteria producing these enzymes are overrepresented, your body keeps recycling estrogen it's trying to clear.

Research shows that the estrobolome is altered in endometriosis. A mouse model study found that endometriosis is associated with estrobolome dysregulation and altered immune metabolism. The exact relationship is complex: it's unclear whether dysbiosis drives endometriosis, whether endometriosis drives dysbiosis, or whether both are true.

Endometriotic lesions themselves also produce estrogen locally through increased aromatase expression — which is one reason hormonal suppression alone doesn't always provide complete symptom relief. The gut and the lesions are both contributing to the estrogenic environment.

How Does the Gut Microbiome Change in Endometriosis?

Multiple studies have documented gut microbiome alterations in endometriosis, including reduced diversity in some bacterial populations, imbalances in composition, and increases in potentially pathogenic bacteria. The dysbiosis disrupts immune function, increases inflammation, and contributes to the chronic inflammatory state.

The most striking recent finding: research published in Gut (2025) demonstrated that gut bacteria can translocate from the intestine into the peritoneal cavity in endometriosis. Gut-derived bacteria, particularly Pseudomonas, cross the intestinal barrier and reach endometriotic lesions, where they trigger immune responses that promote disease progression. Fecal microbiota transplantation from endometriosis patients to mice disrupted the intestinal barrier and promoted this translocation.

This isn't just a correlation between gut health and endo. Bacteria are physically crossing from the gut into the pelvis and making the disease worse.

What About SIBO and Intestinal Permeability?

Small intestinal bacterial overgrowth (SIBO) occurs when bacteria that normally live in the colon colonize the small intestine, where they ferment carbohydrates and produce excessive gas. In a 2025 case-control study of women with endometriosis who underwent breath testing, 91.9% tested positive for SIBO or intestinal methanogen overgrowth, compared to 83.1% of controls without endometriosis. The high prevalence in both groups means this study population was enriched for GI complaints — but among women with endo who have significant digestive symptoms, SIBO is very common. If you're dealing with endo belly, SIBO is one of the mechanisms worth investigating.

Intestinal permeability also appears to be increased in endometriosis. A pilot study found significantly higher plasma levels of lipopolysaccharides (LPS) — bacterial components that shouldn't normally cross the intestinal barrier — in women with endometriosis compared to controls. When bacterial products like LPS enter the bloodstream, they trigger systemic inflammation and immune activation, creating a feedback loop: inflammation damages the gut barrier, more bacterial products cross through, more inflammation follows.

How Does the Gut-Immune Connection Work in Endometriosis?

In endometriosis, immune dysfunction and gut dysbiosis feed each other. The presence of endometrial tissue outside the uterus triggers immune responses, but the immune system fails to clear these ectopic cells effectively. This creates chronic inflammation with elevated cytokines and altered immune cell profiles.

The gut microbiome regulates much of this immune function. When dysbiosis occurs, it impairs immune tolerance and promotes inflammatory responses. The altered immune environment then selects for more dysbiotic bacteria, which further impair immune regulation. This is why addressing the gut in endometriosis isn't optional — the immune dysfunction and the dysbiosis are maintaining each other. It's also one of the reasons endometriosis drives such profound fatigue. Your immune system is running a chronic inflammatory response, and that takes energy.

How Do You Know If Your IBS Is Actually Endometriosis?

The symptom overlap between IBS and endometriosis is substantial: bloating, abdominal pain, altered bowel habits, cramping. But there are patterns that suggest endometriosis is the upstream driver:

Cyclical worsening: If your GI symptoms consistently worsen during menstruation or specific phases of your cycle, that's a pattern IBS alone doesn't explain. Rome criteria for diagnosing IBS don't account for cyclical patterns or gynecological symptoms — which is exactly how endometriosis gets missed.

Symptom clustering: Endometriosis rarely shows up as gut symptoms in isolation. Painful periods, pain with intercourse, chronic pelvic pain, and fatigue alongside GI complaints point to a systemic condition, not a functional bowel disorder.

Treatment resistance: If you've done the FODMAP diet, tried probiotics, cut gluten, and still cycle through the same symptoms monthly — the IBS playbook isn't addressing what's actually happening.

Direct bowel involvement: Endometriotic lesions can infiltrate the bowel wall directly. These may not be visible on standard colonoscopy if they're in the submucosa or serosa. A negative colonoscopy does not rule out endometriosis affecting the bowel.

Treating only the GI symptoms without addressing endometriosis means treating downstream consequences rather than the upstream cause. Dietary modifications can help — a 2025 RCT showed 60% of women with endometriosis responded to a low-FODMAP diet — but they don't address the inflammatory environment driving the dysbiosis.

The connection between endometriosis and GI symptoms involves gut microbiome changes, estrobolome dysregulation, immune dysfunction, bacterial translocation, and in some cases direct bowel involvement. These aren't separate problems — they're interconnected aspects of a systemic inflammatory condition. The gut, the immune system, the hormones, and the nervous system are all involved. Addressing them in isolation is why so many people cycle through partial improvements and relapses.

If you have persistent GI symptoms that worsen with your menstrual cycle, don't accept an IBS diagnosis without being evaluated for endometriosis. And if you have endometriosis with GI symptoms, know that what's happening in your gut is both a consequence of the disease and a driver of its progression. Understanding that connection is the first step toward addressing it.

Heather Yoshimura, NP

Heather Yoshimura, MSN, AGNP-BC

UCSF-trained nurse practitioner specializing in endometriosis. Founder of Luteal Health. Author of The Endo Dilemma.

References

  1. Kumari N, Kumari R, Dua A, et al. (2024). From gut to hormones: unraveling the role of gut microbiota in (phyto)estrogen modulation in health and disease. Molecular Nutrition & Food Research.
  2. Benagiano G, Pluchino N, Archer D, Stanczyk FZ. (2026). Estrobolome: is there a missing link? The Journal of Steroid Biochemistry and Molecular Biology.
  3. Alghetaa H, Mohammed A, Singh NP, et al. (2023). Estrobolome dysregulation is associated with altered immunometabolism in a mouse model of endometriosis. Frontiers in Endocrinology.
  4. Simons M, Cline M, Gubbels A, et al. (2024). Endometriosis is associated with higher healthcare utilization and upper gastrointestinal symptoms. Clinical Gastroenterology and Hepatology.
  5. Ye F, Li L, Ruan F, et al. (2026). A previous history of endometriosis elevates irritable bowel syndrome risk in middle-aged and older women: a UK Biobank cohort study. Digestive Diseases and Sciences.
  6. DiVasta AD, Zimmerman LA, Vitonis AF, Fadayomi AB, Missmer SA. (2021). Overlap between irritable bowel syndrome diagnosis and endometriosis in adolescents. Clinical Gastroenterology and Hepatology.
  7. Saidi K, Sharma S, Ohlsson B. (2020). A systematic review and meta-analysis of the associations between endometriosis and irritable bowel syndrome. European Journal of Obstetrics, Gynecology, and Reproductive Biology.
  8. Nabi MY, Nauhria S, Reel M, et al. (2022). Endometriosis and irritable bowel syndrome: a systematic review and meta-analyses. Frontiers in Medicine.
  9. Chiaffarino F, Cipriani S, Ricci E, et al. (2020). Endometriosis and irritable bowel syndrome: a systematic review and meta-analysis. Archives of Gynecology and Obstetrics.
  10. Salliss ME, Farland LV, Mahnert ND, Herbst-Kralovetz MM. (2021). The role of gut and genital microbiota and the estrobolome in endometriosis, infertility and chronic pelvic pain. Human Reproduction Update.
  11. Halfon P, Estrade JP, Penaranda G, et al. (2025). High prevalence of small intestinal bacterial overgrowth and intestinal methanogen overgrowth in endometriosis patients: a case-control study. International Journal of Gynaecology and Obstetrics.
  12. Viganó D, Zara F, Pinto S, et al. (2020). How is small bowel permeability in endometriosis patients? A case control pilot study. Gynecological Endocrinology.
  13. Wu X, Wu M, Li H, et al. (2025). Intraperitoneal translocation of gut microbiota induces NETosis and promotes endometriosis. Gut.
  14. Velho RV, Werner F, Mechsner S. (2023). Endo belly: what is it and why does it happen? A narrative review. Journal of Clinical Medicine.
  15. As-Sanie S, Mackenzie SC, Morrison L, et al. (2025). Endometriosis. JAMA.
  16. Taylor HS, Kotlyar AM, Flores VA. (2021). Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet.
  17. Varney JE, So D, Gibson PR, et al. (2025). Effect of a 28-day low FODMAP diet on gastrointestinal symptoms associated with endometriosis. Alimentary Pharmacology & Therapeutics, 61(12), 1889–1903.